Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Grants Accelerated Approval to Pembrolizumab for Hepatocellular Carcinoma

americanpharmaceuticalreviewNovember 14, 2018

Tag: carcinoma , FDA , pembrolizumab

PharmaSources Customer Service